Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ESOMEPRAZOLE STRONTIUM

ESOMEPRAZOLE STRONTIUM

Standard Dose
24.65MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ESOMEPRAZOLE STRONTIUM is listed in Drugs@FDA under application 202342 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ESOMEPRAZOLE STRONTIUM Form and strength CAPSULE, DELAYED RELEASE;ORAL - 24.65MG Sponsor BELCHER Submission history Latest submission status date: 2022-03-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESOMEPRAZOLE STRONTIUM is listed in Drugs@FDA under application 202342 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESOMEPRAZOLE STRONTIUM Form and strength CAPSULE, DELAYED RELEASE;ORAL - 24.65MG Sponsor BELCHER Submission history Latest submission status date: 2022-03-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.